OTCMKTS:MYRX - Myrexis Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0250 0.00 (0.00 %) (As of 05/19/2019 04:00 PM ET)Previous Close$0.0250Today's Range$0.0250 - $0.025052-Week Range$0.0070 - $0.0638Volume36,920 shsAverage Volume50,662 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABeta4.03 ProfileChartDividendEarningsFinancialsHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York. Receive MYRX News and Ratings via Email Sign-up to receive the latest news and ratings for MYRX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:MYRX Previous Symbol CUSIPN/A CIK1459450 Webwww.myrexis.com Phone801-214-7800Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Myrexis (OTCMKTS:MYRX) Frequently Asked Questions What is Myrexis' stock symbol? Myrexis trades on the OTCMKTS under the ticker symbol "MYRX." Has Myrexis been receiving favorable news coverage? Press coverage about MYRX stock has trended somewhat positive on Sunday, according to InfoTrie. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Myrexis earned a media sentiment score of 1.9 on InfoTrie's scale. They also assigned media coverage about the biopharmaceutical company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days. Who are some of Myrexis' key competitors? Some companies that are related to Myrexis include Advanced Accelerator Application (AAAP), Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), American Oriental Bioengineering (AOBI), Aoxing Pharmaceutical (AOXG), Aralez Pharmaceuticals (ARLZ), ARMO Biosciences (ARMO), Bohai Pharmaceuticals Group (BOPH), Cardiome Pharma (CRME), Concordia International (CXRXD), Concordia International (CXRX), Depomed (DEPO), Egalet (EGLT), Eleven Biotherapeutics (EBIO) and Epirus Biopharmaceuticals (EPRSQ). What other stocks do shareholders of Myrexis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Myrexis investors own include Histogenics (HSGX), Scivanta Medical (SCVM), Petroteq Energy (PQEFF), Propanc Biopharma (PPCB), VAALCO Energy (EGY), Canopy Growth (CGC), Amarin (AMRN), New Age Brands (NF) and FSD Pharma (HUGE). Who are Myrexis' key executives? Myrexis' management team includes the folowing people: Mr. Jonathan M. Couchman, Chairman, CEO, Pres, CFO & Principal Accounting Officer (Age 49) How do I buy shares of Myrexis? Shares of MYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Myrexis' stock price today? One share of MYRX stock can currently be purchased for approximately $0.0250. What is Myrexis' official website? The official website for Myrexis is http://www.myrexis.com. How can I contact Myrexis? Myrexis' mailing address is C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260, NEW YORK NY, 10020. The biopharmaceutical company can be reached via phone at 801-214-7800 or via email at [email protected] MarketBeat Community Rating for Myrexis (OTCMKTS MYRX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 63 (Vote Outperform)Underperform Votes: 53 (Vote Underperform)Total Votes: 116MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe MYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYRX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: Outstanding Shares, Buying and Selling Stocks Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.